Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. [Phase 1]
This is a Phase 1 dose-escalation and expansion study evaluating intratumoral ONM-501 alone and in combination with cemiplimab in patients w…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers [NA]
Clinical trial investigating light therapy and occupational therapy fatigue-management for bladder, kidney, and prostate cancer patients is …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Blue Light Cystoscopy With Cysview® Registry
This clinical trial registry update describes ongoing blue light cystoscopy research using Cysview for bladder cancer. Recruitment is curren…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Image-Guided Gynecologic Brachytherapy [NA]
A recruiting clinical trial is investigating image-guided gynecologic brachytherapy across cervical, endometrial (uterine), vaginal, vulvar,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy [Phase 2]
Phase 2 trial evaluating futibatinib in combination with durvalumab prior to cystectomy for patients with muscle-invasive bladder cancer ine…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium [Phase 2]
A Phase 2 clinical trial evaluating prophylactic cranial irradiation for small cell carcinoma of the urothelium in bladder cancer is current…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Virtual Histology of the Bladder Wall for Bladder Cancer Staging [EARLY_Phase 1]
This early-phase 1 trial update describes using virtual histology of the bladder wall to stage bladder cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Sexual Quality of Patients After Bladder Cancer Cystectomy
This clinical trial reports on sexual function outcomes in patients who underwent bladder cancer cystectomy, with the study status now compl…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
A clinical study comparing FGFR testing results obtained from ctDNA blood testing to standard tumor tissue testing in metastatic bladder can…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion [NA]
A clinical trial evaluating chlorhexidine antiseptic irrigation of the bowel segment during radical cystectomy with urinary diversion for bl…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) [NA]
A clinical trial evaluating the clinical utility of online adaptive radiotherapy in bladder cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer [Phase 2]
This Phase 2 neoadjuvant trial evaluates Visugromab, an anti-GDF-15 antibody, in combination with immunotherapy for muscle-invasive bladder …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) [Phase 3]
The INCyst Phase 3 trial is investigating whether preoperative immunonutrition affects postoperative morbidity and immune response after cys…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer [EARLY_Phase 1]
Clinical trial update: a Phase 1 study evaluating bladder perfusion with plasma-activated saline for bladder cancer; the trial is not yet re…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers [Phase 2]
Phase 2 trial evaluating therapeutic plasma exchange in combination with enfortumab vedotin and pembrolizumab for metastatic bladder urothel…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer. [NA]
This clinical trial update describes a personalized six-month program aimed at reducing frailty in older patients treated for bladder cancer…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]
Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
This clinical trial is evaluating non-invasive assays for detecting urothelial cancer, with recruitment currently ongoing. The study is spon…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma [Phase 2]
Phase 2 study evaluating neoadjuvant adebrelimab plus etoposide and cisplatin for neuroendocrine carcinoma of the bladder, with recruitment …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
This clinical trial update reports that City of Hope Medical Center's remote telemonitoring study of patient-generated physiological data an…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
This clinical trial update describes an ongoing study led by Istituto Clinico Humanitas investigating DRG gene mutations as a guide for enha…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating entinostat in combination with chemotherapy for locally advanced or metastatic bladder cancer. Recr…